Aerocrine AB – Strategic SWOT Analysis Review

Date: 2015-11

“Aerocrine AB – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – GlobalData’s summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.


Aerocrine AB (Aerocrine), a subsidiary of Circassia Pharmaceuticals Plc, is a medical products company. It markets and sells medical devices and tests. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. The company offers nitric oxide (NO) monitoring devices. The company products find application diagnosis, treatment and control of inflammation. The company offers these products to hospitals, research clinics, and healthcare units. The company distributes its products through subsidiaries in the US, Germany, and through distributors in Japan, Canada, Poland, Portugal, Spain, Australia, and South America, among others.

Aerocrine AB Key Recent Developments

Jul 13, 2015 Aerocrine is delisted today
Jun 26, 2015 Aerocrine applies for delisting
May 12, 2015 Aerocrine Sales Grow to Record Levels Again for 1st Quarter, NIOX VERO Launch in the US Off to A Strong Start
Apr 16, 2015 Changes in Aerocrine’s Executive Leadership Team
Feb 20, 2015 Aerocrine Achieves Record Sales for the 4th Quarter and Full Year

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample